Abstract:Objective: The Tubridge flow diverter (TFD) was recently developed to treat intracranial aneurysm (IA). In this study, we aimed to assess the safety and efficacy of this novel device. Methods: A retrospective cohort of consecutive patients with IA was recruited between June 2017 and February 2022. The studied outcomes were perioperative complications, clinical quality of life, and angiographic IA occlusion. Multivariate logistic regression was performed to explore the potential predictors of perioperative stroke events and IA occlusion. A comprehensive literature review was conducted across five databases for evidence synthesis. Results: Among the patients with IA in our cohort, 144 underwent successful TFD implantation. Postoperative stroke was observed in 11 (7.6%) patients, and 130 (90.3%) patients were discharged with modified Rankin scales (mRS) of ≤2. In the last clinical follow-up (mean, 16.9 months), 96.6% of the patients reported a satisfactory quality of life (mRS ≤2). IA occlusion was observed in 84.6% of the patients at the last angiographic follow-up (mean, 10.4 months). Aneurysmal subarachnoid hemorrhage [odds ratio (OR), 6.98; 95% confidence interval (CI), 1.11-43.91] and giant IA (OR, 5.63; 95% CI, 1.15-27.48) were associated with perioperative stroke events. The evidence synthesis found high rates of satisfactory quality of life (rate, 98.8%; 95% CI, 97.1-99.9%) and IA obliteration (rate, 78.5%; 95% CI, 74.0-82.7%) after TFD treatment. The pooled complication rate was 13.6% (95% CI, 10.9-16.5%). Conclusions: This study identified a high rate of IA occlusion in patients who received TFD treatment. These patients also reported a satisfactory quality of life. Further studies in larger prospective cohorts with longer follow-up periods are warranted to verify our findings. Key message What is already known on this topic Flow diverter (FD) devices are an optimal tool to modify hemodynamics and treat intracranial aneurysms (IAs). However, the safety and efficacy of a novel self-expanding FD, namely the Tubridge flow diverter (TFD), remain to be fully established owing to the short-term follow-up periods and limited sample size of existing studies. What this study adds In our cohort of patients who received TFD treatment, 96.6% of patients reported satisfactory quality of life at the last clinical follow-up (mean, 16.9 months); and 84.6% of IAs were successfully occluded at the last angiographic follow-up (mean, 10.4 months). Our comprehensive review and evidence synthesis of existing studies on TFD found high rates of satisfactory quality of life (98.8%; 97.1-99.9%) and IA obliteration (78.5%; 74.0-82.7%). How this study might affect research, practice or policy TFD demonstrated satisfactory performance in the treatment of IAs in our cohort. Studies with larger prospective cohorts and longer follow-up periods are warranted to further investigate this promising novel approach.

Tubridge Flow Diverter or in Combination with Coils for Treatment of Large or Giant Anterior Circulation Aneurysms:A Follow-Up Observation

Tubridge Flow Diverter for the Treatment of Small and Medium Aneurysms

Tubridge Flow Diverter for the Treatment of Large and Giant Cavernous Carotid Aneurysms: a Long-Term Follow-Up Study

A novel flow-diverting device (Tubridge) for the treatment of 28 large or giant intracranial aneurysms: a single-center experience.

Treatment of intracranial aneurysms with Tubridge flow diverter: A single-center experience

Use of the Tubridge flow diverter in the treatment of intracranial aneurysms: a single center experience

Preliminary study of the Tubridge flow diverter in the treatment of internal carotid artery dissection

Evaluating the Tubridge™ Flow Diverter for Large Cavernous Carotid Artery Aneurysms.

The use of novel flow diverting device Tubridge for the treatment of intracranial aneurysms: initial experience

A Novel Flow Diverter (Tubridge) For The Treatment Of Recurrent Aneurysms: A Single-Center Experience

Long-Term Outcome of Tubridge Flow Diverter(S) in Treating Large Vertebral Artery Dissecting Aneurysms—A Pilot Study

Safety analysis of branch arteries covered by Tubridge flow diverters in treatment of intracranial aneurysms

Flow diverter device Tubridge in intracranial complex aneurysms: an efficacy and safety analysis

A novel flow diverter device (Tubridge) for the treatment of intracranial aneurysms: a systematic review and meta-analysis.

Treatment of intracranial aneurysms using the Tubridge flow diverter

Hemodynamic Effect of Flow Diverter and Coils in Treatment of Large and Giant Intracranial Aneurysms

Parent Artery Reconstruction for Large or Giant Cerebral Aneurysms Using a Tubridge Flow Diverter (PARAT): Study Protocol for a Multicenter, Randomized, Controlled Clinical Trial

Different Interventional Treatments of Large or Giant Intracranial Aneurysms:a Single Center Experience

Tubridge flow diverter alone vs. Tubridge flow diverter and coils for the treatment of intracranial aneurysms: A propensity score matching analysis

Flow Diversion for Aneurysms Beyond the Circle of Willis: A Preliminary Experience.

Clinical Outcomes On Tubridge Flow Diverter in Treatmenting Intracranial Aneurysms: a Retrospective Multicenter Registry Study